Comments
Loading...
Bicara Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BCAX | Benzinga
Bicara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 16
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Bicara Therapeutics using advanced sorting and filters.
Bicara Therapeutics (BCAX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-0.39 | $-0.29 | -34.5 % |
Bicara Therapeutics (BCAX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Bicara Therapeutics (NASDAQ:BCAX) reporting earnings?
Bicara Therapeutics (BCAX) is scheduled to report earnings on May 16, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Bicara Therapeutics (NASDAQ:BCAX)?
The Actual EPS was $-0.39, which missed the estimate of $-0.29.
What were Bicara Therapeutics’s (NASDAQ:BCAX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.